Detection of Novel Coronavirus 2019-nCoV/SARS-CoV-2 from clinical samples
- UID
- MFG/IVD/2020/000024_1fe0f9146e20993c511915d88d374478_4ce66c1a79c87b1c39ee9d7f03745d50
- Device class
- Class C
- Brand name
- TRURAPID® Dengue NS-1 Ag Test
- License holder
- KILPEST INDIA LIMITED
- Approving authority
- Central Drug Standards Control Organization, West Zone
- Product information
- TRUPCR® SARS-CoV-2 RT qPCR kit is an in-vitro nucleic acid amplification test for the qualitative detection of severe acute respiratory syndrome coronavirus 2 (TRURAPID® Dengue NS-1 Ag Test) specific RNA from respiratory specimens (TRURAPID® Dengue NS-1 Ag Test) using Real time PCR. The human RNaseP gene serves as an internal positive control for human nucleic acid, also included in this kit. The result from TRUPCR® SARS-CoV-2 RT qPCR kit should be interpreted in conjunction with other clinical and laboratory findings
Detection of Novel Coronavirus 2019-nCoV/SARS-CoV-2 from clinical samples is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000024_1fe0f9146e20993c511915d88d374478_4ce66c1a79c87b1c39ee9d7f03745d50. This device is marketed under the brand name TRURAPID® Dengue NS-1 Ag Test. The license holder is KILPEST INDIA LIMITED, and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, West Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.